{"result": "(\"entity\"<|>HU J<|>PERSON<|>Hu J is an author involved in research on glutamine supplementation and its effects on cytokine levels in patients undergoing hematopoietic stem cell transplantation.)\n##\n(\"entity\"<|>ZHANG D<|>PERSON<|>Zhang D is an author contributing to the study of glutamine supplementation in hematopoietic stem cell transplantation patients.)\n##\n(\"entity\"<|>HUANG W<|>PERSON<|>Huang W is an author who participated in research regarding glutamine supplementation effects on Th1/Th2 cytokines.)\n##\n(\"entity\"<|>YI X<|>PERSON<|>Yi X is an author involved in the study of glutamine supplementation in patients undergoing hematopoietic stem cell transplantation.)\n##\n(\"entity\"<|>LI D<|>PERSON<|>Li D is an author contributing to the research on the effects of glutamine supplementation.)\n##\n(\"entity\"<|>CHINESE JOURNAL OF CLINICAL NUTRITION<|>ORGANIZATION<|>The Chinese Journal of Clinical Nutrition publishes research articles related to clinical nutrition, including studies on glutamine supplementation.)\n##\n(\"entity\"<|>BLOOD<|>ORGANIZATION<|>Blood is a journal that publishes research on hematology, including studies on non-Hodgkin lymphoma and its treatment.)\n##\n(\"entity\"<|>SUPPORTIVE CARE IN CANCER<|>ORGANIZATION<|>Supportive Care in Cancer is a journal that publishes research on supportive care for cancer patients, including nutritional support during treatments.)\n##\n(\"entity\"<|>BONE MARROW TRANSPLANT<|>ORGANIZATION<|>Bone Marrow Transplant is a journal that focuses on research related to bone marrow transplantation and its complications.)\n##\n(\"entity\"<|>NUTRITION HOSPITAL<|>ORGANIZATION<|>Nutrition Hospital is a journal that publishes studies on nutritional support in clinical settings, including for patients undergoing bone marrow transplantation.)\n##\n(\"entity\"<|>INTERNATIONAL JOURNAL OF ONCOLOGY<|>ORGANIZATION<|>The International Journal of Oncology publishes research related to cancer treatment and supportive care, including studies on nutritional support.)\n##\n(\"entity\"<|>PARENTERAL NUTRITION<|>EVENT<|>Parenteral nutrition refers to the intravenous administration of nutrients, which is often used in patients undergoing treatments like bone marrow transplantation.)\n##\n(\"relationship\"<|>HU J<|>CHINESE JOURNAL OF CLINICAL NUTRITION<|>Hu J is an author of a study published in the Chinese Journal of Clinical Nutrition regarding glutamine supplementation<|>8)\n##\n(\"relationship\"<|>ZHANG D<|>CHINESE JOURNAL OF CLINICAL NUTRITION<|>Zhang D is an author of a study published in the Chinese Journal of Clinical Nutrition regarding glutamine supplementation<|>8)\n##\n(\"relationship\"<|>HUANG W<|>CHINESE JOURNAL OF CLINICAL NUTRITION<|>Huang W is an author of a study published in the Chinese Journal of Clinical Nutrition regarding glutamine supplementation<|>8)\n##\n(\"relationship\"<|>YI X<|>CHINESE JOURNAL OF CLINICAL NUTRITION<|>Yi X is an author of a study published in the Chinese Journal of Clinical Nutrition regarding glutamine supplementation<|>8)\n##\n(\"relationship\"<|>LI D<|>CHINESE JOURNAL OF CLINICAL NUTRITION<|>Li D is an author of a study published in the Chinese Journal of Clinical Nutrition regarding glutamine supplementation<|>8)\n##\n(\"relationship\"<|>MITTAL S<|>BLOOD<|>Mittal S is an author of a study published in Blood regarding the induction of regulatory T-cell populations in non-Hodgkin lymphoma<|>8)\n##\n(\"relationship\"<|>RZEPECKI P<|>SUPPORTIVE CARE IN CANCER<|>Rzepecki P is an author of a study published in Supportive Care in Cancer regarding blood and marrow transplantation and nutritional support<|>8)\n##\n(\"relationship\"<|>TAKATSUKA H<|>BONE MARROW TRANSPLANT<|>Takatsuka H is an author of a study published in Bone Marrow Transplant regarding oral eicosapentanoic acid for complications of bone marrow transplantation<|>8)\n##\n(\"relationship\"<|>ELIA M<|>INTERNATIONAL JOURNAL OF ONCOLOGY<|>Elia M is an author of a study published in the International Journal of Oncology regarding enteral nutritional support and eicosapentanoic acid in cancer patients<|>8)\n##\n(\"relationship\"<|>BROWN SA<|>BONE MARROW TRANSPLANT<|>Brown SA is an author of a study published in Bone Marrow Transplant regarding parenteral glutamine protecting hepatic function during transplantation<|>8)\n##\n(\"relationship\"<|>GOMEZ CANDELA C<|>NUTRITION HOSPITAL<|>Gomez Candela C is an author of a study published in Nutrition Hospital regarding the effects of parenteral glutamine in bone marrow transplantation<|>8)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: , Hu J, Zhang D, Huang W, Yi X, Li D et al. Effects of glutamine supplementation on Th1/Th2 cytokines level in patients undergoing hematopoietic stem cell transplantation. Chin J Clin Nutr 2006; 14: 365–368.\n---\nTema 41. Soporte nutricional en el paciente hematológico (trasplante de médula ósea y enfermedad)...    673\n\n74. Mittal S, Marshall NA, Duncan L, Culligan DJ, Barker RN, Vickers MA. Local and systemic induction of CD4+CD25+ regulatory T-cell population by non-Hodgkin lymphoma. Blood 2008; 111: 5359–5370.\n\n75. Rzepecki P, Barzal J, Oborska S. Blood and marrow transplantation and nutritional support. Support Care Cancer (2010) 18 (Suppl 2): S57–S65.\n\n76. Takatsuka H, Takemoto Y, Iwata N. Oral eicosapentanoic acid for complications of bone marrow transplantation. Bone Marrow Transplant 2001; 28: 769-774.\n\n77. Takatsuka H, Takemoto Y, Yamada S. Oral eicosapentanoic acid for acute colonic graft-versus-host disease after BMT. Drugs Exp Clin Res 2002; 28: 121-125.\n\n78. Elia M, Van Bokhorst MAE, Garvey J, Goedhart A, Lundholm K, Nitenberg G, Stratton RJ. Enteral (oral or tube administration) nutritional support and eicosapentanoic acid in patients with cancer: a systemic review. Int J Oncol 2006; 28(1):5-23.\n\n79. Blijlevens NM, Donnelly JP, Naber AH, Schattenberg AV, DePauw BE. A randomised, double-blinded, placebocontrolled, pilot study of parenteral glutamine for allogeneic stem cell transplant patients. Support Care Cancer 2005; 13:790–796.\n\n80. Brown SA, Goringe A, Fegan C, Davies SV, Giddings J, Whittaker JA et al. Parenteral glutamine protects hepatic function during bone marrow transplantation. Bone Marrow Transplant 1998; 22: 281–284.\n\n81. Canovas G, Leon-Sanz M, Gomez P, Valero MA, Gomis P, La Huerta JJ. Oral glutamine supplements in autologous hematopoietic transplant: impact on gastrointestinal toxicity and plasma protein levels. Haematologica 2000; 85: 1229–1230.\n\n82. Coghlin Dickson TM, Wong RM, Offrin RS, Shizuru JA, Johnston LJ, Hu WW et al. Effect of oral glutamine supplementation during bone marrow transplantation. J Parenter Enteral Nutr 2000; 24: 61–66.\n\n83. Torres HOG, Vilela EG, Cunha AS, Goulart EMA, Souza MHC, Aguirre ACC et al. Glutamine dipeptide enriched parenteral nutrition significantly increase short-term survival after HLA-identical allogeneic stem cell transplantation. Blood 2006; 108: 11: S180–S181 (abstr. 598).\n\n84. Gomez Candela C, Castillo R, de Cos AI, Iglesias C, Martin MC, Aguado MJ et al. Effects of parenteral glutamine in patients submitted to bone marrow transplantation. Nutr Hosp 2006; 21: 13–21.\n\n85. Gomez Candela C, Castillo R, Cos AI, Iglesias C, Aguado MJ, Ojeda E. Glutamine-supplemented parenteral nutrition in bone marrow transplanted patients. Clin Nutr 2001; 20 (Suppl 2): S26 (abstr. D2-0190).\n\n86. Jebb SA, Marcus R, Elia M. A pilot study of oral glutamine supplementation in patients receiving bone marrow transplants. Clin Nutr 1995; 14: 162–165.\n\n87. Masszi T, Batai A, Remenyl P, Reti M, Krivan G. ABMT patients benefit from glutamine supplementation of total parenteral nutrition. Bone Marrow Transplant 2000; 25 (Suppl1): S240 (abstr. P765).\n\n88. Picardi M, Selleri C, Volpicelli M, Rotoli B. Effect of early administration of high-dose oral glutamine in allogeneic bone marrow transplanted patients. Bone Marrow Transplant 2001; 27 (Suppl 1): S338 (abstr. P815).\n\n89. Piccirillo N, De Matteis S, Laurenti L, Chiusolo P, Sora F, Rutella S et al. Glutamine-enriched parenteral nutrition after autologous peripheral blood stem cell transplantation: effects on immune reconstitution and mucositis. Bone Marrow Transplant 2002; 29 (Suppl 2): S21 (abstr. O148).\n\n90. Piccirillo N, De Matteis S, Laurenti L, Chiusolo P, Sora F, Pittiruti M et al. Glutamine-enriched parenteral nutrition after autologous peripheral blood stem cell transplantation: effects on immune reconstitution and mucositis. Haematologica 2003; 88: 192–200.\n\n91. Pytlik R\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}